BCI
JAZZ icon

Brinker Capital Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brinker Capital Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Buy
23,454
+837
+4% +$183K 0.04% 358
2026
Q1 		$4.28M Sell
22,617
-6,105
-21% -$1.07M 0.04% 419
2025
Q4 		$4.88M Sell
28,722
-1,520
-5% -$233K 0.04% 446
2025
Q3 		$3.99M Buy
30,242
+602
+2% +$72.2K 0.03% 510
2025
Q2 		$3.15M Sell
29,640
-1,311
-4% -$142K 0.03% 560
2025
Q1 		$3.84M Buy
30,951
+326
+1% +$42.5K 0.04% 431
2024
Q4 		$3.77M Buy
30,625
+8,235
+37% +$971K 0.04% 412
2024
Q3 		$2.49M Sell
22,390
-1,986
-8% -$218K 0.02% 581
2024
Q2 		$2.6M Buy
24,376
+3,480
+17% +$383K 0.03% 526
2024
Q1 		$2.52M Buy
20,896
+688
+3% +$84.3K 0.03% 551
2023
Q4 		$2.54M Sell
20,208
-3,518
-15% -$439K 0.03% 522
2023
Q3 		$3.07M Sell
23,726
-157
-0.7% -$20.9K 0.04% 434
2023
Q2 		$2.96M Sell
23,883
-730
-3% -$98.2K 0.03% 490
2023
Q1 		$3.6M Buy
24,613
+1,064
+5% +$157K 0.04% 354
2022
Q4 		$3.75M Sell
23,549
-34
-0.1% -$4.98K 0.07% 265
2022
Q3 		$3.14M Sell
23,583
-541
-2% -$82.3K 0.07% 289
2022
Q2 		$3.76M Sell
24,124
-1,078
-4% -$166K 0.07% 267
2022
Q1 		$3.92M Buy
25,202
+2,309
+10% +$335K 0.06% 301
2021
Q4 		$2.92M Buy
22,893
+124
+0.5% +$16.3K 0.04% 429
2021
Q3 		$4.04M Hold
22,769
– – 0.06% 322
2021
Q2 		$4.04M Buy
22,769
+10,127
+80% +$1.75M 0.05% 369
2021
Q1 		$2.08M Sell
12,642
-9,742
-44% -$1.6M 0.03% 504
2020
Q4 		$3.69M Buy
22,384
+1,939
+9% +$289K 0.06% 400
2020
Q3 		$2.92M Buy
+20,445
New +$2.53M 0.05% 354

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Brinker Capital Investments's JAZZ Position: Q2 2026 in Review

Brinker Capital Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 3.7% in Q2 2026, buying an estimated $183K and bringing the position to 23,454 shares worth $5.65M. The position accounts for 0.04% of the portfolio, ranked #358.

Brinker Capital Investments first reported a position in JAZZ in Q3 2020 and has held it in 24 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Brinker Capital Investments held 23,454 shares of Jazz Pharmaceuticals worth $5.65M as of Q2 2026.
  • Brinker Capital Investments bought 837 Jazz Pharmaceuticals shares in Q2 2026, an estimated $183K.
  • Jazz Pharmaceuticals made up 0.04% of Brinker Capital Investments's portfolio in Q2 2026, its #358 holding.
  • Brinker Capital Investments first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.